LS
Latha Sri Bura
About Latha Sri Bura
Data last updated:
Latha Sri Bura is a Director at Libramed Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Libramed Pharmaceuticals Private Limited reported revenue of ₹4.63 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Oct 2022 | 2019 | ₹4.63 Cr (FY 2025) | Active |
Board colleagues of Latha Sri Bura
| Name | DIN | Company | Designation |
|---|---|---|---|
| Balakrishna Dyavanapelly | 08411140 | Libramed Pharmaceuticals Private Limited | Director |
| Bharath Gajula | 09772398 | Libramed Pharmaceuticals Private Limited | Director |
| Mahendhar Punnam | 08411254 | Libramed Pharmaceuticals Private Limited | Director |
| Pannala Mahipal Reddy | 08519892 | Libramed Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Latha Sri Bura
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Latha Sri Bura
Latha Sri Bura currently holds 1 directorship: Libramed Pharmaceuticals Private Limited (Director, since 21 Oct 2022, revenue ₹4.63 Cr (FY 2025)).
Latha Sri Bura was first appointed on 21 Oct 2022 as Director at Libramed Pharmaceuticals Private Limited.
The current boards of Latha Sri Bura's companies include Balakrishna Dyavanapelly (Libramed Pharmaceuticals Private Limited), Bharath Gajula (Libramed Pharmaceuticals Private Limited), Mahendhar Punnam (Libramed Pharmaceuticals Private Limited), Pannala Mahipal Reddy (Libramed Pharmaceuticals Private Limited).